The burgeoning trend in metabolic health is undoubtedly centered around GLP-1 medications , and BrightMeds is leading this wave . These groundbreaking drugs, initially designed for treating type 2 diabetes, are now widely prescribed – or being explored – for their impressive ability to promote re